The Anatomy of a Biosimilar Label

June 2018

Medical oncologist Dr. Andrew Zelenetz clarifies the differences between the label of a biosimilar and that of its reference product.

Under the FDA's guidance, the label of a biosimilar and its reference product are essentially the same. ­Dr. Andrew Zelenetz explores the implications of this. Clear and transparent labels are key in helping to ensure precise prescribing decisions. Visit for more info.
Comments are disabled for this content.